USE OF MOXONIDINE FOR POSTMYOCARDIAL INFARCTION TREATMENT

摘要

The invention relates to the use of moxonidine and the physiologically compatible acid additional salts thereof for producing pharmaceutical preparations for the treatment of myocardial infarction damages of the myocardium. Moxonidine and pharmaceutical preparations which contain physiologically compatible acid additional salts of moxonidine are suitable for use in acute myocardial infarction treatment and/or postmyocardial infarction treatment.